Loading organizations...
Loading organizations...
Drug development for tissue repair and inflammatory bowel disease.
Rodeo Therapeutics has raised $5.9M across 1 funding round.
Rodeo Therapeutics has raised $5.9M in total across 1 funding round.
Rodeo Therapeutics has raised $5.9M in total across 1 funding round.
Rodeo Therapeutics's investors include AbbVie Ventures, Alexandria Venture Investments, ARCH Venture Partners, Eli Lilly and Company, Johnson & Johnson Innovation, Watson Fund, WRF Capital, WuXi AppTec.
Rodeo Therapeutics has raised $5.9M across 1 funding round. Most recently, it raised $5.9M Series A in July 2017.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 25, 2017 | $5.9M Series A | AbbVie Ventures, Alexandria Venture Investments, ARCH Venture Partners, Eli Lilly and Company, Johnson & Johnson Innovation, Watson Fund, WRF Capital, WuXi AppTec |